Edward Kramer, MD
Procedural Dermatology · Anaheim, CANPI 1548302243
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 382 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations.
Across 382 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Incyte Corporation$888
- Pfizer$759
- UCB, Inc.$631
- Sun Pharmaceutical Industries Inc.$627
- Johnson & Johnson$565
- plus $2K from 22 others
What the payments were for
- Travel & lodging$20%
- Food & beverage$7,09599%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 132 | $1,709 |
| Incyte Corporation | 61 | $888 |
| Pfizer | 41 | $759 |
| UCB, Inc. | 17 | $631 |
| Sun Pharmaceutical Industries Inc. | 38 | $627 |
| Johnson & Johnson | 20 | $565 |
| Merz North America, Inc. | 7 | $351 |
| Lilly USA, LLC | 11 | $316 |
| Sanofi | 7 | $210 |
| Dermavant Sciences, Inc. | 1 | $147 |
| AbbVie(2 entities) | 5 | $131 |
| Mimedx Group, Inc. | 4 | $112 |
| Almirall LLC | 5 | $109 |
| Journey Medical Corporation | 8 | $102 |
| LEO Pharma Inc. | 3 | $80 |
| Amgen | 3 | $75 |
| Sanofi-aventis U.S. LLC | 3 | $72 |
| Galderma Laboratories, L.p. | 4 | $70 |
| VYNE Pharmaceuticals Inc. | 1 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Verrica Pharmaceuticals Inc. | 1 | $28 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Sandoz | 1 | $21 |
| Apyx Medical Corporation | 1 | $19 |
| Biofrontera Inc. | 2 | $18 |
| Prugen, Inc. Pharmaceuticals | 1 | $15 |
| Dermira, Inc. | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,197 in reported general payments places this provider in the 65th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 115 | $3,800 |
| Clobetasol Propionate | 24 | $1,552 |
| Doxycycline Hyclate | 35 | $630 |
| Triamcinolone Acetonide | 60 | $299 |
| Mupirocin | 41 | $257 |
| Ketoconazole | 17 | $239 |
| ValacyclovirValacyclovir Hcl | 17 | $113 |
| Prednisone | 12 | $46 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Anaheim
- David FriedmanAnaheim$3K
- Sam Khalifianla Mesa$3.5M
- Sabrina FabiSan Diego$3.1M
- Natasha MesinkovskaMission Viejo$499K
- Jeanette BlackLos Angeles$492K
- Mitchel GoldmanSan Diego$425K
- Rebecca FitzgeraldLos Angeles$230K
- Suzanne KilmerSacramento$220K
- Zakia RahmanStanford$181K
- Hrak JalianSanta Monica$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.